A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Bird flu has descimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily change as influenza can rapidly change.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

H5N1 bird flu has been found to infect mammals more extensively. Although there has yet to be evidence of human-to-human ...